- Exchange: NASDAQ CM
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Therapeutics
DARA Biosciences Inc
+ Add to WatchlistDARA:US
0.7600 USD 0.0500 7.04%As of 20:10:00 ET on 05/22/2013.
Snapshot for DARA Biosciences Inc (DARA)
| Open: | 0.7200 | Day's Range: | 0.7018 - 0.7600 | Volume: | 353,372 |
|---|---|---|---|---|---|
| Previous Close: | 0.7600 | 52wk Range: | 0.6151 - 1.3800 | 1-Yr Rtn: | -10.59% |
Key Statistics for DARA
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (USD) (ttm) | -0.5100 |
| Est. EPS (USD) (12/2013) | -0.3200 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 19.00 |
| Shares Outstanding (M) | 25.00 |
| 30 Day Average Volume | 325,837 |
| Price/Book (mrq) | 1.4941 |
| Price/Sale (ttm) | 201.5100 |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 08/14/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for DARA
Company Profile & Key Executives for DARA
DARA BioSciences, Inc. is a development stage pharmaceutical company. The Company acquires therapeutic molecules and medical technologies directly or through investment in established companies. DARA focuses on small molecules from late preclinical development through phase 2 clinical trials for neuropathic pain, metabolic diseases, and dermatological disorders.
| Christopher G ClementPresident/COO | David J DrutzCEO/Chief Medical Officer |
| David L TousleyChief Financial Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
DARA News
-
Industry News
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page